Aquila provides cost-effective, accurate and timely nucleic acid-based point-of-care diagnostic testing for infectious diseases from unprocessed samples. Our technology is extremely robust, with successful laboratory and field-testing across human (malaria), animal, water, and aquaculture targets. We are preparing to commercialize worldwide, including markets in North America and Europe.

Latest News

posted on July 18, 2014 Be a part of the Aquila Team
Now hiring for the position of Director of Engineering.

-
-

posted on July 08, 2014 Accutas™ Lab-On-A-Chip Malaria Detection Kit Featured on ABC News
July 8, 2014  - Australia -  Aquila's Accutas™ Lab-On-A-Chip malaria detection kit and Dr. Stephanie Yanow are featured on ABC News.

-
-

posted on June 28, 2014 Aquila Receives Federal WINN Funding
June 27, 2014 - Calgary, AB, Canada - Aquila receives new Federal Government funding under the Western Innovation (WINN) Initiative at an announcement today.

-
-

posted on June 24, 2014 Research showing the effectiveness of Aquila's Accutas™ Lab-On-A-Chip published in Malaria Journal
Research into Aquila's Accutas™ Lab-On-A-Chip system published in the May 2014 issue of Malaria Journal shows the technology's effectiveness at diagnosing malaria. Using patient samples from Uganda, the diagnostic exceeded the standards for microscopy by ten- to fifty-fold, with sensitivity (97.4%) and specificity (93.8%) compared to conventional real-time PCR.

-
-

posted on March 24, 2014 Aquila's Accutas™ Lab-On-A-Chip Featured in Apple Magazine
March 24, 2014 - Edmonton, AB, Canada - The Accutas™ system is recognized among groundbreaking healthcare innovations in Alberta Health Service's Apple magazine.

-
-

posted on March 13, 2014 Aquila Diagnostic Systems Unveils New Accutas™ Lab-On-A-Chip March 13, 2014 – Edmonton, AB, Canada – With a favourable assessment from the Geneva-based Foundation for Innovative New Diagnostics (FIND), Edmonton's Aquila Diagnostic Systems has achieved an important milestone in the development of their point-of-care Accutas™ Lab-On-A-Chip malaria detection kit. 

-
-

posted on November 08, 2013 Aquila featured in Alberta Venture Magazine October 1, 2013  - Edmonton, AB, Canada - Aquila's backstory as a fledgling startup company gaining steam is profiled in Alberta Venture. 

-
-

Testimonials

“This new technology... opens up the possibility of using a simple and highly sensitive molecular test at the point-of-care for the diagnosis of malaria and other blood-borne infections.”
Chief Scientific Officer Mark Perkins, Foundation for Innovative New Diagnostics (FIND), Geneva, in a favourable assessment showing Aquila’s Accutas™ diagnostic system achieved results superior to current malaria testing systems.
 

Supporters

Alberta Innovates
Broadport Canada Inc
nanobridge small
Western Economic Diversification Canada 120w

9207 117 Street, Edmonton, Alberta, Canada   T6G 1S3

   Subscribe to our newsletter